World Health Organization Issues Concern Over Critical Scarcity of Obesity Medications
Under one in 10 individuals that would benefit from weight-loss injections such as Wegovy have access to them, caution the World Health Organization as it issues its inaugural recommendations on the medications.
Given in excess of 1,000,000,000 individuals worldwide now living with obesity, it is urging broader and more equitable availability to this class of drugs.
According to projections, more than two billion will be living with obesity by 2030 without intervention.
"Our new guidance affirms that excess weight is a lifelong illness that can be addressed with comprehensive and ongoing support," said WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and supply-chain constraints are key obstacles to universal availability to the treatments that can aid individuals in losing considerable body mass, says the organization.
GLP-1 Therapy Shortage
Even under the present most optimistic outlook, the manufacturing of these medications could only cover about 100 million people – under 10% of those who need them, as stated by the health organization.
The guideline calls on countries and companies to widen access, through measures such as voluntary licensing.
A patent on a key compound – the main ingredient of Novo Nordisk's Wegovy – is scheduled to end in several countries in 2026.
How Obesity Jabs Operate
These medications mimick a biological compound to reduce digestion speed, reduce hunger and boost feelings of fullness so people consume fewer calories.
People typically begin shedding pounds within a few weeks of beginning the regular doses.
Studies suggests people may put most of the weight back on within a year of halting the medication, because their normal appetite return.
To be overweight or obese increases your likelihood for developing medical conditions, like type 2 diabetes, cardiovascular issues, brain attack, and certain cancers.
Obesity impacts people in every country and was responsible for over three and a half million fatalities worldwide in 2024, according to the health agency.